| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.550 | 18.202 | 22.702 | 34.708 | 35.222 | - | - | - | 52.083 | - |
| Total Income - EUR | 7.550 | 18.202 | 22.702 | 34.739 | 35.222 | - | - | - | 52.083 | - |
| Total Expenses - EUR | 15.236 | 18.552 | 21.464 | 37.834 | 29.772 | - | - | - | 38.998 | - |
| Gross Profit/Loss - EUR | -7.686 | -350 | 1.238 | -3.096 | 5.451 | - | - | - | 13.085 | - |
| Net Profit/Loss - EUR | -7.906 | -564 | 578 | -3.443 | 5.274 | - | - | - | 12.674 | - |
| Employees | 2 | 3 | 2 | 3 | 3 | - | - | - | 2 | - |
Check the financial reports for the company - Symbiosis Fv S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 6.853 | 5.849 | 5.793 | 4.826 | - | - | - | 1.348 | - |
| Current Assets | 289 | 1.058 | 868 | 1.909 | 6.528 | - | - | - | 8.961 | - |
| Inventories | 120 | 124 | 114 | 221 | 724 | - | - | - | 710 | - |
| Receivables | 0 | 301 | 4 | 0 | 0 | - | - | - | 4.043 | - |
| Cash | 169 | 632 | 750 | 1.688 | 5.804 | - | - | - | 4.207 | - |
| Shareholders Funds | -7.861 | -8.344 | -7.625 | -10.928 | -5.443 | - | - | - | 2.333 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | - | - | 40 | - |
| Debts | 8.150 | 16.256 | 14.341 | 18.630 | 16.796 | - | - | - | 7.976 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Symbiosis Fv S.r.l.